Abstract
Anti-benzo[a]pyrene-7,8-diol-9,10-epoxide (anti-BPDE) is a metabolite of benzo[a]pyrene (B[a]P) and acts as a potent mutagen in mammalian systems. However, molecular mechanisms related to anti-BPDE-induced carcinogenesis are poorly understood. Here, we investigated the expression of proto-oncogene c-myc in human bronchial epithelial cells (16HBE-T) transformed by exposure to anti-BPDE. The levels of mRNA and protein of c-Myc were examined in the 16HBE-T and vehicletreated control cells (16HBE-N) by using different methods respectively, including reverse transcriptase-polymerase chain reaction (RT-PCR), quantitative real-time PCR (Q-PCR), western blot and immunocytochemical methods. The level of c-myc mRNA appeared to be significantly increased in 16HBE-T, as compared with those of the 16HBE-N. Likewise, the expression of c-Myc protein was significantly enhanced as compared with those of the control cells. Moreover, the localization of c-Myc protein shows mainly nuclear staining in 16HBE-T. In conclusion, the abnormal expression of c-Myc was present in anti-BPDE malignantly transformed 16HBE cells, which may be involved in the carcinogenesis molecular mechanism of anti-BPDE.
Similar content being viewed by others
References
Pavanello S, Pulliero A, Saia B O, Clonfero E. Determinants of anti-benzo[a]pyrene diol epoxide-DNA adduct formation in lymphomonocytes of the general population. Mutat Res, 2006, 611(1–2): 54–63
Burdick A D, Davis J W 2nd, Liu K J, Hudson L G, Shi H, Monske ML, Burchiel SW. Benzo(a)pyrene quinones increase cell proliferation, generate reactive oxygen species, and transactivate the epidermal growth factor receptor in breast epithelial cells. Cancer Res, 2003, 63(22): 7825–7833
Gunter M J, Divi R L, Kulldorff M, Vermeulen R, Haverkos K J, Kuo MM, Strickland P, Poirier MC, Rothman N. Sinha R. Leukocyte polycyclic aromatic hydrocarbon-DNA adduct formation and colorectal adenoma. Carcinogenesis, 2007, 28(7): 1426–1429
Conney A H. Induction of microsomal enzymes by foreign chemicals and carcinogenesis by polycyclic aromatic hydrocarbons: G. H. A. Clowes Memorial Lecture. Cancer Res, 1982, 42(12): 4875–4917
Rojas M, Marie B, Vignaud J M, Martinet N, Siat J, Grosdidier G, Cascorbi I. Alexandrov K. High DNA damage by benzo[a]pyrene 7,8-diol-9,10-epoxide in bronchial epithelial cells from patients with lung cancer: comparison with lung parenchyma. Cancer Lett, 2004, 207(2): 157–163
Schwerdtle T, Seidel A, Hartwig A. Effect of soluble and particulate nickel compounds on the formation and repair of stable benzo[a]pyrene DNA adducts in human lung cells. Carcinogenesis, 2002, 23(1): 47–53
Denissenko M F, Pao A, Tang M, Pfeifer G P. Preferential formation of benzo[a]pyrene adducts at lung cancer mutational hotspots in P53. Science, 1996, 274(5286): 430–432
Shen Y M, Troxel A B, Vedantam S, Penning T M. Field J. Comparison of p53 mutations induced by PAH o-quinones with those caused by anti-benzo[a]pyrene diol epoxide in vitro: role of reactive oxygen and biological selection. Chem Res Toxicol, 2006, 19(11): 1441–1450
Wu X, Zhao Y, Honn S E, Tomlinson G E, Minna J D, Hong W K, Spitz M R. Benzo[a]pyrene diol epoxide-induced 3p21.3 aberrations and genetic predisposition to lung cancer. Cancer Res, 1998, 58(8): 1605–1608
Pavanello S, Favretto D, Brugnone F, Mastrangelo G, Dal Pra G, Clonfero E. HPLC/fluorescence determination of anti-BPDE-DNA adducts in mononuclear white blood cells from PAH-exposed humans. Carcinogenesis, 1999, 20(3): 431–435
Srivastava S K, Bansal P, Oguri T, Lazo J S, Singh S V. Cell division cycle 25B phosphatase is essential for benzo(a)pyrene-7,8-Diol-9,10-epoxide induced neoplastic transformation. Cancer Res, 2007, 67(19): 9150–9157
Nasi S, Ciarapica R, Jucker R, Rosati J and Soucek L. Making decisions through Myc. FEBS Letters, 2001, 490(3): 153–162
Richardson G E, Johnson B E. The biology of lung cancer. Semin Oncol, 1993, 20(2): 105–127
Broers J L, Viallet J, Jensen SM, Pas H, Travis WD, Minna J D, Linnoila R I. Expression of c-myc in progenitor cells of the bronchopulmonary epithelium and in a large number of nonsmall cell lung cancers. Am J Respir Cell Mol Biol, 1993, 9(1): 33–43
Zajac-Kaye M. Myc oncogene: a key component in cell cycle regulation and its implication for lung cancer. Lung Cancer, 2001, 34(Suppl 2): S43–S46
Jiang Y, Chen J. Chen X. Malignant transformation of human bronchial epithelial cells induced by benzo(a)pyrene metabolite dihydroxyepoxy benzo pyrene. Weisheng Yanjiu, 2001, 30(3): 129–131 (in Chinese)
Quattrone A Papucci L, Santini V, Schiavone N, Noferini D, Calastretti A, Copreni E, Morelli S, Rossi Ferrini P L, Nicolin A, Capaccioli S. Quantitation of bcl-2 oncogene in cultured lymphoma/leukemia cell lines and in primary leukemia B-cells by a highly sensitive RT-PCR method. Haematologica, 1995, 80(6): 495–504
Akerman G S, Rosenzweig B A, Domon O E, McGarrity L J, Blankenship L R, Tsai C A, Culp S J, MacGregor J T, Sistare F D, Chen J J, Morris S M. Gene expression profiles and genetic damage in benzo(a)pyrene diol epoxide-exposed TK6 cells. Mutat Res, 2004, 549(1–2): 43–64
Castorina A, Tiralongo A, Cavallo D, Loreto C, Carnazza M L, Iavicoli S, Agata V D. Expression profile of ErbB receptor’s family in human alveolar type 2-like cell line A549 exposed to hexavalent chromium. Toxicol in Vitro, 2008, 22(2): 541–547
Goidin D, Mamessier A, Staquet M J, Schmitt D, Berthier-Vergnes O. Ribosomal 18SRNAprevails over glyceraldehyde-3-phosphate dehydrogenase and b-actin genes as internal standard for quantitative comparison of mRNA levels in invasive and non invasive human melanoma cell subpopulations. Anal Biochem, 2001, 295(1): 17–21
IARC, International Agency for Research on Cancer. IARC monographs on the evaluation of carcinogenic risks to humans, Air pollution. Part I. Some non-heterocyclic polycyclic aromatic hydrocarbons and some related industrial exposures. Lyon, 2005, 92, in preparation
Fu J, Jiang Y G, Bin X N, Ji W D, Wang M. Effect of chlorophyllin on malignant transformation cell cycle and proliferation in vitro in human bronchial epithelial cells. Zhongguo Gonggong Weisheng, 2005, 21(4): 423–424 (in Chinese)
Boxer LM, Dang C V. Translocations involving c-myc and cmyc function. Oncogene. 2001, 20(40): 5595–5610
Dang C V. c-Myc target genes involved in cell growth, apoptosis, and metabolism. Mol Cell Biol, 1999, 19(1): 1–11
Little C D, Nam MM, Carney D N, Gazdar A F, Minna J D. Amplification and expression. of the c-myc oncogene in human lung cancer cell lines. Nature, 1983, 306(5939): 194–196
Gosney J R, Field J K, Gosney M A, Lye M D, Spandidos D A, Butt S A. c-myc oncoprotein in bronchial carcinoma: expression in all major morphological types. Anticancer Res, 1990, 10(3): 623–628
Popescu N C, Zimonjic D B. Chromosome-mediated alterations of the MYC gene in human cancer. J Cell Mol Med, 2002, 6(2): 151–159
Fields WR, Desiderio J G, Leonard RM, Burger E E, Brown B G, Doolittle D J. Differential c-myc expression profiles in normal human bronchial epithelial cells following treatment with benzo[a]pyrene, benzo[a]pyrene-4,5 epoxide, and benzo [a]Pyrene-7,8-9,10 diol epoxide. Mol Carcinog, 2004, 40(2): 79–89
Author information
Authors and Affiliations
Corresponding authors
Rights and permissions
About this article
Cite this article
Fu, J., Jiang, Y. & Chen, X. Abnormal expression of c-Myc in human bronchial epithelial cells malignantly transformed by anti-BPDE. Front. Med. China 2, 380–385 (2008). https://doi.org/10.1007/s11684-008-0073-3
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11684-008-0073-3